Starton Therapeutics
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
215 College Rd Ste 300, Paramus, New Jer...Phone Number
(800) 449-5405Website
www.startontx.comRevenue
$7.1 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Starton Therapeutics
Starton Therapeutics is a clinical-stage biotechnology company dedicated to enhancing standard-of-care therapies through its proprietary continuous delivery technology systems. The company focuses on improving pharmacokinetic profiles of FDA-approved drugs, aiming to provide better treatment outcomes for patients, particularly those with cancer. Starton develops various delivery methods, including subcutaneous and transdermal systems, catering to individualized patient needs. Their goal is to replace and expand existing therapies while addressing unmet medical needs in the oncology space.Explore more
Starton Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Starton Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Starton Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Starton Therapeutics is spiking on competitors!
Product Launch: Get notified when Starton Therapeutics launches new products
Click to see if Starton Therapeutics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Starton Therapeutics has new funding data
Earning: See what the market has to say on Starton Therapeutics recently announced quarterly report
Starton Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Starton Therapeutics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Starton Therapeutics
Compare insights from companies similar to Starton Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Starton Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Starton Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Starton Therapeutics.
Starton Therapeutics Tech Stack
A closer look at the technologies used by Starton Therapeutics
See more technologies
Most Recent Scoops
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Pharmaceuticals
Person-Based
Project
Product Development, Product Management, Intellectual Property, Legal Affairs, Governmental Affairs & Regulation, Pharmaceuticals, Regulations
Person-Based
Event
Events
Starton Therapeutics News & Media
Starton Therapeutics Files Patent Application for the Use of Multi-Specific Antibody-Based Therapies in Combination with its Proprietary, Continuous Low-Dose Immunomodulatory Therapy, STAR-LLD, a formulation of Lenalidomide, for the Treatment of Blood Cancer
PARAMUS, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company employing standard-of-care therapies with proprietary continuous delivery technologies, announced today that it has filed a patent application for the use of multi-specific (i.e., bi- and tri-specific) antibody-based therapies in combination with the Company’s proprietary, continuous low-dose IMiD, which is a subcutaneous administration of lenalidomide, STAR-LLD, for theStarton Therapeutics Announces Dosing of First Patient in Phase 2a Study Evaluating STAR-LLD for the Treatment of Multiple Myeloma
PARAMUS, N.J., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technologies, announced today the dosing of the first patient in its Phase 2a study evaluating STAR-LLD for the treatment of relapsed/refractory multiple myeloma (RRMM).Starton Therapeutics to Present at Biotech Showcase 2026
Company Will Also Host 1x1 Investor Meetings at the 15th Annual LifeSci Partners Corporate Access Event from January 13-14th in San Francisco Company Will Also Host 1x1 Investor Meetings at the 15th Annual LifeSci Partners Corporate Access Event from January 13-14th in San FranciscoStarton Therapeutics to Share Innovative Lenalidomide Delivery Technology on Labroots Webinar Sponsored by Primetech Corporation
PARAMUS, N.J., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technologies, announced today that its Chief Medical Officer, Dr. Jamie Oliver, Pharm.D., will present in an upcoming Labroots webinar sponsored by Primetech Corporation on October 29, 2025, at 7:00 AM PDT / 10:00 AM EDT / 11:00 PM JST.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Starton Therapeutics
Sign Up For FreeTo access detailed company insights
Starton Therapeutics is a clinical-stage biotechnology company dedicated to enhancing standard-of-care therapies through its proprietary continuous delivery technology systems. The company focuses on improving pharmacokinetic profiles of FDA-approved drugs, aiming to provide better treatment outcomes for patients, particularly those with cancer. St... Read More
